XML 22 R9.htm IDEA: XBRL DOCUMENT
v3.20.2

Condensed Consolidated Financial Statements Details | 9 Months Ended
--- | ---
Sep. 30, 2020
Condensed Consolidated Financial Statements Details |
Condensed Consolidated Financial Statements Details | 3. Condensed Consolidated Financial Statements Details Equity Securities As of September 30, 2020 and December 31, 2019, equity securities consisted of an investment in Rezolute’s common stock of $2.6 million and $0.7 million, respectively (Note 4). For the three and nine months ended September 30, 2020 the Company recognized gains of $2.0 million and $1.9 million, respectively, due to the change in fair value of its investment in Rezolute’s common stock in the other income (expense), net line item of the condensed consolidated statements of operations and comprehensive (loss) income. The Company recognized a loss of $0.3 million and a gain of $0.5 million for the three and nine months ended September 30, 2019. Accrued and Other Liabilities Accrued and other liabilities consisted of the following (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | September 30, | ​ | December 31,
​ |  | 2020 |  | 2019
Accrued legal and accounting fees | ​ | $ | 202 | ​ | $ | 256
Accrued payroll and other benefits | ​ |  | 154 | ​ |  | 231
Interest payable | ​ |  | 51 | ​ |  | 69
Accrued incentive compensation | ​ |  | 26 | ​ |  | 332
Other | ​ |  | 33 | ​ |  | 57
Total | ​ | $ | 466 | ​ | $ | 945
​ Net (Loss) Income Per Share Attributable to Common Stockholders The following is a reconciliation of the numerator (net loss or income) and the denominator (number of shares) used in the calculation of basic and diluted net (loss) income per share attributable to common stockholders (in thousands, except per share amounts): ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended September 30, | ​ | Nine Months Ended September 30,
​ |  | 2020 |  | 2019 |  | 2020 |  | 2019
Numerator |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |
Net (loss) income | ​ | $ | (1,077) | ​ | $ | 3,178 | ​ | $ | (9,368) | ​ | $ | 2,339
Less: Allocation of undistributed earnings to participating securities | ​ |  | — | ​ |  | (1,327) | ​ |  | — | ​ |  | (977)
Net (loss) income available to common stockholders, basic | ​ | ​ | (1,077) | ​ | ​ | 1,851 | ​ | ​ | (9,368) | ​ | ​ | 1,362
Add: Adjustments to undistributed earnings allocated to participating securities | ​ |  | — | ​ |  | 60 | ​ |  | — | ​ |  | 41
Net (loss) income available to common stockholders, diluted | ​ | $ | (1,077) | ​ | $ | 1,911 | ​ | $ | (9,368) | ​ | $ | 1,403
​ | ​ |  | ​ | ​ |  | ​ | ​ |  | ​ | ​ |  | ​
Denominator | ​ |  | ​ | ​ |  | ​ | ​ |  | ​ | ​ |  | ​
Weighted average shares used in computing basic net (loss) income per share available to common stockholders | ​ |  | 11,019 | ​ |  | 8,731 | ​ |  | 10,537 | ​ |  | 8,721
Effect of dilutive stock options | ​ |  | — | ​ |  | 708 | ​ |  | — | ​ | ​ | 657
Effect of dilutive warrants | ​ |  | — | ​ |  | 2 | ​ |  | — | ​ | ​ | 1
Weighted average shares used in computing diluted net (loss) income per share available to common stockholders | ​ |  | 11,019 | ​ |  | 9,441 | ​ |  | 10,537 | ​ |  | 9,379
Basic net (loss) income per share of common stock | ​ | $ | (0.10) | ​ | $ | 0.21 | ​ | $ | (0.89) | ​ | $ | 0.16
Diluted net (loss) income per share of common stock | ​ | $ | (0.10) | ​ | $ | 0.20 | ​ | $ | (0.89) | ​ | $ | 0.15
​ Potentially dilutive securities are excluded from the calculation of diluted net (loss) income per share available to common stockholders if their inclusion is anti-dilutive. The following table shows the weighted-average outstanding securities considered anti-dilutive and therefore excluded from the computation of diluted net (loss) income per share attributable to common stockholders (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended September 30, | ​ | Nine Months Ended September 30,
​ |  | 2020 |  | 2019 |  | 2020 |  | 2019
Convertible preferred stock |  | 5,003 |  | — |  | 5,483 | ​ | —
Common stock options |  | 931 |  | 893 |  | 611 | ​ | 926
Warrants for common stock |  | 19 |  | 15 |  | 21 | ​ | 15
Total |  | 5,953 |  | 908 |  | 6,115 |  | 941
​

X
- Definition The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement. + References No definition available. + Details
Name: | us-gaap_AdditionalFinancialInformationDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Consolidated financial statement detail. + References No definition available. + Details
Name: | xoma_ConsolidatedFinancialStatementDetailAbstract
Namespace Prefix: | xoma_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration